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Available online 5 August 2016Peripheral bloodwasobtained froma 12-year oldmale carrying bialleleic inactivatingmutations at the ATM locus,
causing Ataxia-Telangiectasia (A-T). Blood erythroid cells were brieﬂy expanded in vitro and induced pluripotent
stem cells (iPSCs)were generated via transfectionwith episomal vectors carrying hOCT4, hSOX2, hKLF4, hMYC and
hBCL2L1. SF-003 iPSCswere free of genomically integrated reprogramming genes, had the speciﬁc compound het-
erozygous mutations, stable karyotype, expressed pluripotency markers and formed teratomas in immunodeﬁ-
cient (NOD scid gamma; NGS) mice. The SF-003 iPSC line may be a useful resource for in vitromodeling of A-T.
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a 12-year-old boy compound heterozygous for null frameshift
mutations in ATM exon 23 (3369delA in codon 1123) and exon
26 (3754delTATinsCA in codon 1252). Homozygous mutations in
ATM cause the autosomal recessive syndrome Ataxia-Telangiectasia
(A-T) and, accordingly, the patient clinical presentation was con-
sistent with the “classical” form of A-T. Peripheral blood mono-
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plasmid integration was analyzed by qPCR on iPSC DNA at passage
22 with plasmid-speciﬁc primers, using S18 primers as loading
control (Fig. 1A). These analyses conﬁrmed lack of integration of
the reprogramming plasmids. The cells were karyotypically normal
(Fig. 1B) and Sanger sequencing conﬁrmed the presence of the
3369delA in exon 23 and 3754delTATinsCA in exon 26 (Fig. 1C). Indirect
immunoﬂuorescence conﬁrmed the expression of stem cells markers
TRA-1-60, OCT4, SOX2 and SEEA4 in single cells (Fig. 1D). Finally,
the SF-003 iPSC line formed teratomas in vitro with high efﬁciency
(Fig. 1E), further conﬁrming pluripotency.the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Characterization of the SF-003 iPSC line. A) PCR for vector integration. EBNA1 primers ampliﬁed a fragment common to all three plasmids used for expression of reprogramming
factors (pMOS, pMMKandpGBX). As a loading control,we ampliﬁed18S. B)Karyotypic analyses byG-banding. A representativemetaphase out of 20 is shown. C) Chromatogramof SF-003
gDNA after ampliﬁcation of exons 23 and 26 containingmutations. The consensus sequence is shown on topwithmutated nucleotides highlighted in red. D) Indirect immunoﬂuorescence
for pluripotencymarkers OCT-4, SSEA4, TRA-1-60 and SOX-2. Nuclei were counterstainedwith DAPI. E) Sections of SF-003-derived teratomas after H/E staining. Representative examples
of differentiation to endoderm, mesoderm and ectoderm are shown.
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Reprogramming of peripheral blood mononuclear cells and establishment
of iPSC lines
Peripheral blood (PB) was obtained by venipuncture from a 12-year
old male known to carry frameshift mutations in exon 23 (3369delA,
codon 1123) and exon 26 (3754delTATinsCA in codon 1252) of ATM.
Mononulcear cells were puriﬁed in a Ficoll gradient (Ficoll-Paque
Premium, GE Healthcare) and cultured in serum-free medium (SFM)
supplemented with Stem Cell Factor (SCF), interleukin (IL)-3, humanTable 1
Primers used for ATMmutational analyses.
ATM exon Forward sequence
Exon 23 5′- TTTGTTCTGGAATATGCTTTGG-3′
Exon 26 5′- CTTTAATGCTGATGGTATTAAAACAGholotransferrin, erythropoietin, insulin-like growth factor 1 (IGF-1) and
dexamethasone to expand erythroid progenitors. Cellswere nucleofected
with three plasmids encoding reprogramming factors hOCT4, hKLF4,
hCMYC, hSOX2 and hBCL2L1 and stained for TRA-1-60 after 7 days. TRA-
1-60+ colonies (over 95% of total colonies) were pooled and expanded
in E8 media (Life Technologies) on vitronectin plates.
PCR for integration analyses
PCR was done on genomic DNA using primers that detect
the common backbone for all three plasmids: EBNA-Fw1: 5′-Reverse sequence
5′- TGGTGAAGTAATTTATGGGATATTCA-3′
-3′ 5′- GCCATACCTGTTTTCCCAAT-3′
207N. Bhatt et al. / Stem Cell Research 17 (2016) 205–207ACGATGCTTTCCAAACCACC-3′ and EBNA-Rev1: 5′-CATCATCATCCGGG
TCTCCA-3′. As a control, we ampliﬁed the same DNA with primers to
18S: 18S-F: 5′-GCGAGTACTCAACACCAACATCG-3′ and 18S-R: 5′-
TCAAGTCTCCCCAGCCTTGC-3′.
Karyotyping
SF-003 iPSCs at passage 8were sent to theWiCell Genetic Laboratory
for metaphase preparation and G banding. For each line, 20 metaphases
were analyzed.
Mutation analysis
Genomic DNA from early passage SF-003 cells was sequenced
using primers speciﬁc for exons 23 and 26 containing the mutations
(see Table 1 for primer sequences). PCR products were cloned into
TOPO-TA and sequenced at the Johns Hopkins University Genetic Re-
sources Core Facility using Sanger sequencing.
Indirect immunoﬂuorescence for pluripotency markers
iPSCswere incubatedwith antibodies to pluripotencymarkers OCT4,
SOX2, SSEA4 and TRA-1-60 using the Pluripotent Stem Cells 4-marker
Immunocytochemistry Kit (Life Technologies, A24881), following
manufacturer's instructions. Images were taken using an EVOS FL Auto
Cell Imaging System.
Teratoma formation
iPSCs (pool of 6 wells of a 6-well plate, or approximately 10 million
cells) were mixed 1:1 with Matrigel (Cornig Matrigel hESC-qualiﬁedMatrix, #354277) to a total volume of 200 μl and injected into the
subcultaneous space in the ﬂanks of NOD scid gamma (NGS) mice. For-
malin-ﬁxed teratomas were parafﬁn-embedded at the Johns Hopkins
Histopathology Core Facility and ﬁve noncontiguous (H/E)-stained sec-
tions were analyzed.
Veriﬁcation and authentication
For karyotyping, SF-003 cells at passage 10 were sent to WiCell Ge-
netic Laboratory for metaphse preparation and G banding. A total of
20 metaphases were analyzed. No karyotypic abnormalities were de-
tected. To conﬁrm line identity, iPSC genomic DNA was sequenced
using primers speciﬁc for exons 23 and 26 containing the mutations
(see Table 1 for primer sequences). To assess purity, we conﬁrmed ex-
pression of pluripotency markers TRA-1-60, OCT4, SOX4 and SSE4 in
single cells by indirect immunoﬂuorescence.
Acknowledgements
Wewould like to thank the A-T patient for his generous donation of
blood for these studies and to Dr. Howard Lederman, JennyWright and
Renee Allard at the Johns Hopkins Children's Center A-T Clinic for assis-
tance with patient selection, consent and blood collection.
Reference
Chou, B.K., Gu, H., Gao, Y., Dowey, S.N., Wang, Y., Shi, J., Li, Y., Ye, Z., Cheng, T., Cheng, L.,
2015. A facile method to establish human induced pluripotent stem cells from
adult blood cells under feeder-free and xeno-free culture conditions: a clinically com-
pliant approach. Stem Cells Transl. Med. 4, 320–332.
